The global healthcare industry has suffered unprecedented disruptions that signal broad, far-reaching transformation. As the pandemic has frayed normalcy in business, government and society – the healthcare industry has seen a resurgence in corporate, governmental and consumer interest. Innovations in healthcare technology or telehealth have created opportunities for ambitious direct-to-consumer digital health companies looking to take market share from more established healthcare rivals. A key factor boosting the prevalence of remote healthcare will be the collection of data in the cloud, the ability to analyze it in near-real-time and the ability to present the data to both the consumer and healthcare provider. (Source: 451 Research, “COVID-19 & IoT Accelerate Transition of Healthcare From the Hospital to the Home”).
Join S&P Global Market Intelligence for a deep dive discussion on the implications of Healthcare’s digital evolution, with insights for Big Tech’s role and how investors can align their strategies in this space, and an eye to sustainable practices and greater equity for underserved communities. Attendees of this webinar will gain insights on the following.
- Examine the outlook for Investors looking to deliver breakthrough therapies and vaccines to patients and long-term value for shareholders.
- Areas where digital health can look to build long-term sustainable industry standards of care to align with the UN Sustainable Development Goals– sustainability and equity in distribution and access, reducing CO2 emissions and paper consumption, and Femtech to expand women’s rights for with planning, preparing or avoiding reproductive health for women through affordable digital smartphone apps.